Drug Shortage Report for CHOLESTYRAMINE-ODAN
| Report ID | 106728 |
| Drug Identification Number | 02455609 |
| Brand name | CHOLESTYRAMINE-ODAN |
| Common or Proper name | Cholestyramine for Oral Suspension, USP |
| Company Name | ODAN LABORATORIES LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | CHOLESTYRAMINE RESIN |
| Strength(s) | 4G |
| Dosage form(s) | POWDER FOR SUSPENSION |
| Route of administration | ORAL |
| Packaging size | 30 x 4g |
| ATC code | C10AC |
| ATC description | LIPID MODIFYING AGENTS, PLAIN |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2020-02-19 |
| Estimated end date | 2020-04-27 |
| Actual end date | 2020-04-09 |
| Shortage status | Resolved |
| Updated date | 2020-04-13 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | info@odanlab.com Tel.: 1-800-387-9342 Fax: 1-800-329-6326 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v9 | 2020-04-13 | French | Compare |
| v8 | 2020-04-13 | English | Compare |
| v7 | 2020-03-19 | French | Compare |
| v6 | 2020-03-19 | English | Compare |
| v5 | 2020-03-19 | English | Compare |
| v4 | 2020-03-19 | English | Compare |
| v3 | 2020-02-20 | English | Compare |
| v2 | 2020-02-19 | French | Compare |
| v1 | 2020-02-19 | English | Compare |
Showing 1 to 9 of 9